Skip to content

Use of pegfilgrastim in severe chronic neutropenia

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519009-36-01
Acronym
CDF 711
Enrollment
20
Registered
2025-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe chronic neutropenia (SCN)

Brief summary

Median of absolute neutrophil count (from second to six months-period of study)

Detailed description

Number, type and duration of the infections (from second to six months-period of study), Number of antibiotic courses (from second to six months-period of study), Numbero of hospitalizations (from second to six months-period of study)

Interventions

Sponsors

IRCCS Istituto Giannina Gaslini
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
0 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Median of absolute neutrophil count (from second to six months-period of study)

Secondary

MeasureTime frame
Number, type and duration of the infections (from second to six months-period of study), Number of antibiotic courses (from second to six months-period of study), Numbero of hospitalizations (from second to six months-period of study)

Countries

Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026